The recently approved gene editing therapy for sickle cell disease modifies a different gene to modulate expression and allow the fetal hemoglobin gene to turn on, rather than directly correcting the sickle cell mutation.

Every Sunday: the week’s new conflicts and verdict changes — and nothing else.

Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.